Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
cancer immunotherapy
3
×
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nivolumab
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
eli lilly
fda
gene therapy
medicare
merck
migraine
pembrolizumab
abbvie
What
companies
3
×
bio
ipo
life
new
roundup
science
week
approval
arena’s
biogen’s
biopharmaceutical
biotechs
bounty
cig
club
comeback
continued
convo
corner
crop
deals
delivered
drug
earlier
exceeded
expressing
failures
firms
group
haul
joined
latest
littered
little
met
million
moderna’s
momentum
nasdaq
Language
Current search:
companies
×
cancer
×
" cancer immunotherapy "
×
nivolumab
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M